Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA-270 in COPD: 28-day multiple dose pilot study
2009-009096-35Phase 2Completed
- Sponsor
- Activus Pharma
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of TA-270 in chronic obstructive pulmonary disease (COPD), sponsored by Activus Pharma. Primary endpoints: Change in predictive biomarkers of lung oxidative stress, Change in exhaled 8-isoprostane and 3 more. Started Apr 2009; status: completed.
02
Drugs
TA-270
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-009096-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009096-35.